Prognostic factors of gallbladder cancer (GBC) in patients diagnosed over a period of 20 years: A Canadian province experience.
Nima Toussi(University of Saskatchewan), Shahid Ahmed(Emory University), Duc Le(University of Saskatchewan), Haji Chalchal, Mike Moser(Roswell Park Comprehensive Cancer Center), Shazia Mahmood(University of Saskatchewan), Joshua Gitlin(University of Saskatchewan), Osama Ahmed(University of Saskatchewan), Deepti Ravi(Saskatchewan Health Authority), Noura Alsafar, John M. Shaw(University of Saskatchewan), Rani Kanthan(University of Saskatchewan), Kamal Haider(University of Saskatchewan), Adnan Zaidi(University of Saskatchewan), Dorie-Anna Dueck(University of Saskatchewan), Krishna Daida(University of Saskatchewan), Mussawar Iqbal(University of Saskatchewan), Jocelyn Moore, Kimberly Marie Hagel, Branawan Gowrishankar(University of Saskatchewan)
Cited by 0
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
A Randomized Clinical Trial of Granulocyte Transfusions for Infection in Acute Leukemia
|New England Journal of Medicine|1977|299
The Genotype-Tissue Expression (GTEx) project
|Nature Genetics|2013|266